BioCentury
ARTICLE | Company News

Genomics Collaborative, ActivX proteomics deal

August 8, 2001 7:00 AM UTC

Genomics Collaborative ( Cambridge, Mass.) and ActivX Bioscience (La Jolla, Calif.) will identify and validate proteins and gene targets associated with colon cancer. The companies will use ActiveX's ...